semaglutide for food noise Users Report Major Reduction in “Food Noise” and Better Mental Well-Being: Findings from the INFORM Survey (EASD 2025) Food Noise, Diabetes, and GLP-1s

Additionally, optimizing access and equity in pharmacotherapy, as well as integrating these treatments into comprehensive care models, are critical areas for future investigation

Losing and maintaining more than 10% of body weight is associated with significant reductions in obesity-related complications, including hypertension, type 2 diabetes, and heart disease

Many patients achieve their weight loss goals without ever reaching 10mg, 12.5mg, or 15mg

Weight loss injections, primarily glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly prescribed for weight management in the UK

Lab evaluation is done on a case by case basis

Built for real people Grounded in clinical research and guided by real-world experience our approach is built to help real people achieve lasting, sustainable results